Laporan Laba Rugi 1349 - TTM - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	901	834	925	997	1,036	1,140	1,155	1,013	1,158	1,031	1,080	1,283	1,023	851	809	736	692	709	742	691
Change (%)		-7.42	10.97	7.77	3.86	10.10	1.28	-12.33	14.41	-10.99	4.69	18.83	-20.26	-16.83	-4.88	-9.05	-6.03	2.57	4.55	-6.78
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	62	66	69	73	77	81	84	84	87	86	93	101	86	74	68	62	64	63	69	73
Change (%)		6.41	4.61	6.25	5.12	4.93	3.69	-0.23	3.85	-0.87	7.77	8.62	-14.68	-14.05	-8.73	-8.59	3.83	-1.10	8.16	6.45
% of Revenue	6.90	7.93	7.47	7.37	7.46	7.11	7.27	8.28	7.51	8.37	8.61	7.87	8.43	8.71	8.35	8.40	9.28	8.95	9.25	10.57

Gross Operating Profit	839	768	856	924	958	1,059	1,071	929	1,071	945	987	1,182	937	777	742	674	627	646	673	618
Change (%)		-8.45	11.52	7.90	3.76	10.52	1.10	-13.28	15.37	-11.81	4.41	19.79	-20.74	-17.08	-4.51	-9.09	-6.94	2.95	4.19	-8.13
% of Revenue	93.10	92.07	92.53	92.63	92.54	92.89	92.73	91.72	92.49	91.63	91.39	92.13	91.57	91.29	91.65	91.60	90.72	91.05	90.75	89.43

SG&A	524	482	524	554	579	666	675	650	739	597	630	694	539	450	409	319	257	332	337	337
Change (%)		-8.08	8.70	5.81	4.54	15.01	1.40	-3.70	13.56	-19.15	5.44	10.18	-22.27	-16.48	-9.21	-22.02	-19.25	29.00	1.51	-0.08
% of Revenue	58.18	57.76	56.58	55.55	55.91	58.41	58.48	64.23	63.75	57.90	58.32	54.08	52.71	52.94	50.52	43.32	37.22	46.81	45.45	48.72

R&D	135	139	167	183	196	224	227	229	237	227	233	242	223	244	253	280	311	314	335	338
Change (%)		3.25	19.88	9.71	7.07	14.42	1.21	0.69	3.67	-4.31	2.51	4.18	-7.74	9.07	3.89	10.72	10.90	1.03	6.51	0.88
% of Revenue	14.98	16.70	18.04	18.37	18.93	19.68	19.66	22.58	20.46	22.00	21.54	18.89	21.85	28.65	31.30	38.10	44.96	44.29	45.12	48.82

OpEx	714	691	763	813	867	978	993	970	1,070	917	959	1,045	853	774	735	667	645	717	751	753
Change (%)		-3.24	10.43	6.52	6.69	12.72	1.60	-2.37	10.37	-14.32	4.58	8.96	-18.41	-9.27	-4.97	-9.28	-3.30	11.20	4.69	0.36
% of Revenue	79.30	82.88	82.48	81.51	83.74	85.73	86.00	95.77	92.39	88.94	88.84	81.46	83.36	90.93	90.84	90.61	93.25	101.09	101.23	108.98

Operating Income	186	143	162	184	168	163	162	43	88	114	120	238	170	77	74	69	47	-8	-9	-62
Change (%)		-23.45	13.60	13.69	-8.64	-3.39	-0.65	-73.54	106.08	29.41	5.57	97.42	-28.40	-54.68	-3.97	-6.77	-32.38	-116.59	17.89	579.88
% of Revenue	20.70	17.12	17.52	18.49	16.26	14.27	14.00	4.22	7.61	11.06	11.16	18.54	16.64	9.07	9.16	9.39	6.75	-1.09	-1.23	-8.98

Interest Expense	-6	-6	-4	-3	-1	-1	-1	-1	-2	-2	-2	-3	-3	-3	-2	-2	-1	-1	-1	-1
Change (%)		-8.48	-24.78	-36.58	-51.58	-18.44	15.57	14.62	21.67	-9.55	37.51	23.76	21.95	-3.95	-24.86	-34.24	-46.67	-26.78	7.24	8.73
% of Revenue	-0.68	-0.67	-0.46	-0.27	-0.12	-0.09	-0.11	-0.14	-0.15	-0.15	-0.20	-0.20	-0.31	-0.36	-0.28	-0.21	-0.12	-0.08	-0.09	-0.10

Net Income	191	165	188	201	198	213	213	112	132	138	142	242	191	109	102	111	105	40	40	-25
Change (%)		-13.67	14.21	6.91	-1.31	7.49	-0.09	-47.52	17.59	4.94	2.80	70.88	-21.18	-43.15	-5.93	8.29	-4.93	-62.23	0.80	-162.48
% of Revenue	21.18	19.75	20.33	20.16	19.16	18.71	18.45	11.05	11.35	13.38	13.14	18.90	18.68	12.77	12.63	15.04	15.21	5.60	5.40	-3.62

Source: Capital IQ

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)